Literature DB >> 1679949

Plasma serine in schizophrenics and controls measured by gas chromatography-mass spectrometry.

S Baruah1, R Waziri, T S Hegwood, L M Mallis.   

Abstract

In several previous studies, we reported significantly higher plasma serine concentrations in psychotic (and schizophrenic) subjects compared with nonpsychotic and control subjects. In those studies, we used a gas chromatography technique to assay the amino acids. Perry and Hanson (1985), using cation-exchange chromatography to assay plasma amino acids, found no differences in the plasma serine concentrations of controls compared with schizophrenic patients. They criticized our work on technical grounds and suggested that some other substance was co-eluting with the gas chromatographic serine peaks in our assays. We have now examined the plasma of schizophrenic and control subjects with gas chromatography-mass spectrometry (GC-MS), where accurate amino acid quantitation relative to a known internal standard can be achieved. The results show that the plasma serine concentrations of schizophrenic patients are significantly higher than those of controls. Also, plasma glycine concentrations are significantly higher in schizophrenic patients compared with controls.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679949     DOI: 10.1016/0165-1781(91)90062-t

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  2 in total

Review 1.  Potential role of amino acids in pathogenesis of schizophrenia.

Authors:  Shamaila Saleem; Faiza Shaukat; Anjuman Gul; Mahwish Arooj; Arif Malik
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jul-Sep

2.  Peripheral amino Acid levels in schizophrenia and antipsychotic treatment.

Authors:  Vincenzo De Luca; Emanuela Viggiano; Giovanni Messina; Alessandro Viggiano; Carol Borlido; Andrea Viggiano; Marcellino Monda
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.